Tyler Daniels

Blavity Health is covering the FDA's move toward a temporary "interim access" policy that could let compounding pharmacies dispense certain unapproved peptides, such as BPC-157, while the agency weighs permanent rules. We'd love your take on any of these questions: ---What are peptides, and how do FDA-approved peptide drugs differ from the ones sold through telehealth and online? ---What are the main safety concerns with peptides like BPC-157 (immune reactions, impurities, limited human data)? ---What does "enforcement discretion" mean for patients, and does it mean these products are safe or approved? ---What should someone ask their doctor before trying peptide therapy? Preferred: MD/DO in internal medicine, endocrinology or sports medicine, or PharmD. *Please share your credentials and LinkedIn, and disclose any affiliations with peptide sellers, compounding pharmacies, telehealth companies or wellness clinics.

Blavity Health is covering the FDA's move toward a temporary "interim access" policy that could let compounding pharmacies dispense certain unapproved peptides, such as BPC-157, while the agency weighs permanent rules. We'd love your take on any of these questions: ---What are peptides, and how do FDA-approved peptide drugs differ from the ones sold through telehealth and online? ---What are the main safety concerns with peptides like BPC-157 (immune reactions, impurities, limited human data)? ---What does "enforcement discretion" mean for patients, and does it mean these products are safe or approved? ---What should someone ask their doctor before trying peptide therapy? Preferred: MD/DO in internal medicine, endocrinology or sports medicine, or PharmD. *Please share your credentials and LinkedIn, and disclose any affiliations with peptide sellers, compounding pharmacies, telehealth companies or wellness clinics.

Blavity Health is covering the FDA's proposed temporary policy on compounded peptides and the rise of online sellers using "research use only" labels. We'd love your take on any of these questions: ---What's the difference between a 503A compounding pharmacy, a 503B outsourcing facility and a "research use only" website? ---How can patients check where a pharmacy sources its bulk ingredients (certificate of analysis, FDA-registered facility)? ---What red flags should patients watch for in telehealth or social media peptide marketing? ---Can buying peptides online put consumers at legal or health risk? Preferred: PharmD, especially compounding or regulatory experience. *Please share your credentials and LinkedIn, and disclose any affiliations with peptide sellers, compounding pharmacies or telehealth companies.

Blavity Health is covering NIH's new Vaccinology and Immunology Center, a research study at the NIH Clinical Center that will enroll several hundred people with serious adverse effects after vaccination or long-term symptoms after infection, such as long COVID. We'd love your take on any of these questions: ---Why is it important to study serious adverse events and long-term symptoms, even when they're rare? ---How do researchers tell whether a vaccine or infection caused a problem, versus timing alone? ---How can this research improve vaccine safety and treatment for people who are struggling now? ---What should patients with unexplained post-vaccine or post-infection symptoms do while research continues? Preferred: Immunologists, infectious disease physicians, internal medicine or primary care MD/DO. *Please share your credentials and LinkedIn, and disclose any affiliations with vaccine manufacturers or advocacy organizations.

Blavity Health is covering NIH's new center for studying serious illness after vaccination or infection, and how patients with poorly understood symptoms, such as long COVID, often feel dismissed by doctors. We'd love your take on any of these questions: ---What is medical gaslighting, and why are Black patients more likely to experience it? ---How does having symptoms dismissed affect mental and physical health? ---How can patients document symptoms and advocate for themselves at appointments? ---How can a health research center like this rebuild trust with communities that have reason to be skeptical? Preferred: Licensed psychologists (PhD/PsyD), LCSW, or primary care/internal medicine MD/DO with health equity experience. *Please share your credentials and LinkedIn, and disclose any affiliations.